133 related articles for article (PubMed ID: 3217111)
1. Tumorigenic transformation of rat FR3T3 fibroblasts carrying an activated myc oncogene requires subsequent mutational events.
Mougneau E; Cerni C; Tillier F; Cuzin F
Oncogene Res; 1988; 2(2):177-88. PubMed ID: 3217111
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of an exogenous c-myc gene is insufficient for transformation and tumorigenic conversion of established fibroblasts.
Zerlin M; Julius MA; Cerni C; Marcu KB
Oncogene; 1987 Mar; 1(1):19-27. PubMed ID: 3325875
[TBL] [Abstract][Full Text] [Related]
3. Activated fos oncogene in rat embryo fibroblasts transformed by ras and myc oncogenes.
Denner J; Jandrig B; Spitkovsky DD; Ehm I; Kisselyov FL; Schramm T
Neoplasma; 1988; 35(3):263-70. PubMed ID: 3405335
[TBL] [Abstract][Full Text] [Related]
4. Cooperation between the H-ras oncogene and a truncated derivative of the v-myb oncogene in transformation of hamster embryo fibroblasts.
Merzak A; Dooghe Y; Pironin M; Perbal B; Vigier P
Oncogene; 1992 Oct; 7(10):2031-9. PubMed ID: 1408144
[TBL] [Abstract][Full Text] [Related]
5. Rat fibroblasts expressing high levels of human c-myc transcripts are anchorage-independent and tumorigenic.
Pellegrini S; Basilico C
J Cell Physiol; 1986 Jan; 126(1):107-14. PubMed ID: 3944192
[TBL] [Abstract][Full Text] [Related]
6. Acquisition of a tumorigenic phenotype by a rat ventral prostate epithelial cell line expressing a transfected activated neu oncogene.
Sikes RA; Chung LW
Cancer Res; 1992 Jun; 52(11):3174-81. PubMed ID: 1350510
[TBL] [Abstract][Full Text] [Related]
7. Non-selective analysis of the transformation of FR3T3 rat cells by bovine papillomavirus type 1: regulations of viral transcription associated with phenotypic transformation.
Binétruy B; Schiller J; Lowy D; Cerni C; Cuzin F
Oncogene; 1990 Nov; 5(11):1645-51. PubMed ID: 2176280
[TBL] [Abstract][Full Text] [Related]
8. Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.
Duddy SK; Earp HS; Russell WE; Smith GJ; Grisham JW
Cell Growth Differ; 1995 Mar; 6(3):251-61. PubMed ID: 7794793
[TBL] [Abstract][Full Text] [Related]
9. Rapid induction of an experimental metastatic phenotype in first passage rat embryo cells by cotransfection of EJ c-Ha-ras and c-myc oncogenes.
Storer RD; Allen HL; Kraynak AR; Bradley MO
Oncogene; 1988 Feb; 2(2):141-7. PubMed ID: 3285293
[TBL] [Abstract][Full Text] [Related]
10. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
11. Rat embryo fibroblasts transformed by c-Jun display highly metastatic and angiogenic activities in vivo and deregulate gene expression of both angiogenic and antiangiogenic factors.
Kraemer M; Tournaire R; Dejong V; Montreau N; Briane D; Derbin C; Binétruy B
Cell Growth Differ; 1999 Mar; 10(3):193-200. PubMed ID: 10099833
[TBL] [Abstract][Full Text] [Related]
12. Mouse fibroblasts transformed with the human c-myc gene express a high level of mRNA but a low level of c-myc protein and are non-tumorigenic in nude mice.
Ray R; Thomas S; Miller DM
Oncogene; 1989 May; 4(5):593-600. PubMed ID: 2657574
[TBL] [Abstract][Full Text] [Related]
13. Transformation of rodent immortalized and embryo cells by oncogenes. II. Rat embryo fibroblasts (REF).
Denner J; Jandrig B; Ehm I; Schramm T
Arch Geschwulstforsch; 1987; 57(6):475-85. PubMed ID: 3435226
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic modulation of keratins, vimentin, and alpha-fetoprotein in cultured rat liver epithelial cells after chemical, oncogene, and spontaneous transformation.
Bisgaard HC; Ton PT; Nagy P; Thorgeirsson SS
J Cell Physiol; 1994 Jun; 159(3):485-94. PubMed ID: 7514612
[TBL] [Abstract][Full Text] [Related]
15. Transformation of diploid human fibroblasts by DNA transfection with the v-sis oncogene.
Fry DG; Milam LD; Maher VM; McCormick JJ
J Cell Physiol; 1986 Aug; 128(2):313-21. PubMed ID: 3015989
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression and state of the c-myc oncogene in chemically and X-ray-transformed C3H/10T1/2 Cl 8 mouse embryo fibroblasts.
Billings PC; Shuin T; Lillehaug J; Miura T; Roy-Burman P; Landolph JR
Cancer Res; 1987 Jul; 47(14):3643-9. PubMed ID: 2439194
[TBL] [Abstract][Full Text] [Related]
17. Resistance of murine LTA cells to oncogene--mediated progression from tumorigenic to metastatic phenotype.
Tuck AB; Wilson SM; Chambers AF
Anticancer Res; 1990; 10(6):1507-14. PubMed ID: 2285224
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
Spandidos DA
Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
[TBL] [Abstract][Full Text] [Related]
19. [Expression of cell surface transformation-associated antigens TAAs on activated oncogene-transfected rat fibroblast and antitumor immunity by hosts].
Sato N; Yagihashi A; Konno A; Torigoe T; Kikuchi K
Gan To Kagaku Ryoho; 1989 Mar; 16(3 Pt 2):653-61. PubMed ID: 2705790
[TBL] [Abstract][Full Text] [Related]
20. A 3' truncation of myc caused by chromosomal translocation in a human T-cell leukemia is tumorigenic when tested in established rat fibroblasts.
Aghib DF; Bishop JM
Oncogene; 1991 Dec; 6(12):2371-5. PubMed ID: 1766681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
